Influencing the Wnt signaling pathway in multiple myeloma.

作者: Karoline Meschenmoser , Guido Reifenberger , Ingo G H Schmidt-Wolf , Tomoyuki Endo , Sanna-Marie Gast

DOI:

关键词:

摘要: Recent studies have implicated genetic and epigenetic aberrations resulting in aberrant activation of the Wingless-Int (Wnt) pathway thus influencing initiation progression multiple myeloma (MM). Of major importance, these findings may lead to novel treatment strategies exploiting targeted modulation Wnt signaling. This review describes current status knowledge concerning role alteration MM outlines future lines research their clinical perspectives.

参考文章(42)
Desheng Lu, Dennis Carson, Ingo G.H. Schmidt-Wolf, Young Kim, Petra Alpmann, Sabine Blaum-Feder, Simon Krämer, Tomoyuki Endo, In vivo efficacy of griseofulvin against multiple myeloma. Leukemia Research. ,vol. 35, pp. 1070- 1073 ,(2011) , 10.1016/J.LEUKRES.2010.10.008
Ken M Cadigan, Yan I Liu, Wnt signaling: complexity at the surface Journal of Cell Science. ,vol. 119, pp. 395- 402 ,(2006) , 10.1242/JCS.02826
Zongbing You, Daniel Saims, Shaoqiong Chen, Zhaocheng Zhang, Denis C. Guttridge, Kun-liang Guan, Ormond A. MacDougald, Anthony M.C. Brown, Gerard Evan, Jan Kitajewski, Cun-Yu Wang, Wnt signaling promotes oncogenic transformation by inhibiting c-Myc–induced apoptosis Journal of Cell Biology. ,vol. 157, pp. 429- 440 ,(2002) , 10.1083/JCB.200201110
Sheri L. Holmen, Cassandra R. Zylstra, Aditi Mukherjee, Robert E. Sigler, Marie-Claude Faugere, Mary L. Bouxsein, Lianfu Deng, Thomas L. Clemens, Bart O. Williams, Essential Role of β-Catenin in Postnatal Bone Acquisition Journal of Biological Chemistry. ,vol. 280, pp. 21162- 21168 ,(2005) , 10.1074/JBC.M501900200
Nagato Sato, Takumi Yamabuki, Atsushi Takano, Junkichi Koinuma, Masato Aragaki, Ken Masuda, Nobuhisa Ishikawa, Nobuoki Kohno, Hiroyuki Ito, Masaki Miyamoto, Haruhiko Nakayama, Yohei Miyagi, Eiju Tsuchiya, Satoshi Kondo, Yusuke Nakamura, Yataro Daigo, Wnt Inhibitor Dickkopf-1 as a Target for Passive Cancer Immunotherapy Cancer Research. ,vol. 70, pp. 5326- 5336 ,(2010) , 10.1158/0008-5472.CAN-09-3879
Sabine Blaum-Feder, Petra Alpmann, Ingo G H Schmidt-Wolf, Tomoyuki Endo, Desheng Lu, Simon Krämer, Young Kim, Dennis Carson, Increased In Vivo Efficacy of Lenalidomide by Addition of Piroctone Olamine in Vivo. ,vol. 25, pp. 99- 103 ,(2011)
Donald A. Glass, Peter Bialek, Jong Deok Ahn, Michael Starbuck, Millan S. Patel, Hans Clevers, Mark M. Taketo, Fanxin Long, Andrew P. McMahon, Richard A. Lang, Gerard Karsenty, Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast Differentiation Developmental Cell. ,vol. 8, pp. 751- 764 ,(2005) , 10.1016/J.DEVCEL.2005.02.017
Takashi Oshima, Masahiro Abe, Jin Asano, Tomoko Hara, Kenichi Kitazoe, Etsuko Sekimoto, Yoichi Tanaka, Hironobu Shibata, Toshihiro Hashimoto, Shuji Ozaki, Shinsuke Kido, Daisuke Inoue, Toshio Matsumoto, Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood. ,vol. 106, pp. 3160- 3165 ,(2005) , 10.1182/BLOOD-2004-12-4940
Ya-Wei Qiang, Bo Hu, Yu Chen, Ying Zhong, Bingyin Shi, Bart Barlogie, John D. Shaughnessy, Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling Blood. ,vol. 113, pp. 4319- 4330 ,(2008) , 10.1182/BLOOD-2008-08-174300